Clinical trial
Bupropion SR for Treating Smokeless Tobacco Use
NCT00414180 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00414180 |
|---|---|
| Title | Bupropion SR for Treating Smokeless Tobacco Use |
| Official title | Bupropion SR for Treating Smokeless Tobacco Use |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | West Virginia University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smokeless Tobacco |
| Intervention type | Drug |
| Interventions | Bupropion SR |
| Enrollment | 225 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Dec 21, 2006 |
| Last update posted | Mar 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: